• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

BioNTech SE - American Depositary Shares (NQ:BNTX)

107.15 -0.35 (-0.33%)
Streaming Delayed Price Updated: 3:56 PM EDT, Aug 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 731,112
Open 105.02
Bid (Size) 107.13 (1)
Ask (Size) 107.19 (1)
Prev. Close 107.50
Today's Range 104.64 - 107.48
52wk Range 76.53 - 131.49
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
A Look Ahead: BioNTech's Earnings Forecast
Today 11:04 EDT
 
Via Benzinga
Moderna's Key Patent Win Overshadowed By Gloomy Outlook
Today 8:44 EDT
Moderna beat Q2 earnings and revenue estimates, narrowed its annual forecast, won a key patent case, and plans to cut 10% of its global workforce. 
Via Benzinga
Topics Intellectual Property

Performance

YTD
-7.1%
-7.1%
1 Month
-0.3%
-0.3%
3 Month
+4.6%
+4.6%
6 Month
-11.4%
-11.4%
1 Year
+24.3%
+24.3%

More News

Read More
Bristol Myers Cuts Earnings Outlook As Legacy Drugs Face Generic Erosion
July 31, 2025
Via Benzinga
Where Will Pfizer (PFE) Be in 5 Years?
July 31, 2025
Via The Motley Fool
Topics Intellectual Property
Robert Kennedy Jr Blasts Vaccine Injury Compensation Program: 'Devolved Into A Morass Of Inefficiency, Favoritism, And Outright Corruption'
July 28, 2025
Via Benzinga
Pfizer and BioNTech Receive Positive CHMP Opinion for LP.8.1-adapted COVID-19 Vaccine in the European Union
July 25, 2025
From Pfizer Inc.
Via Business Wire
Pfizer and BioNTech Receive Positive CHMP Opinion for LP.8.1-Adapted COVID-19 Vaccine in the European Union
July 25, 2025
From BioNTech SE
Via GlobeNewswire
BioNTech to Report Second Quarter 2025 Financial Results and Corporate Update on August 4, 2025
July 21, 2025
From BioNTech SE
Via GlobeNewswire
BioNTech Announces Ryan Richardson to Step Down from the Management Board
July 17, 2025
From BioNTech SE
Via GlobeNewswire
Breaking Down BioNTech: 12 Analysts Share Their Views
July 16, 2025
Via Benzinga
Why Is AbbVie Stock Trading Higher On Thursday?
July 10, 2025
Via Benzinga
FDA Grants Complete Approval To Moderna's COVID-19 Vaccine For Children As Young As 6 Months
July 10, 2025
Via Benzinga
Topics Intellectual Property
AstraZeneca In $15B Talks For Drug That Could Upend Lung Cancer Treatment
July 03, 2025
Via Benzinga
Ex-Pfizer Exec Pulled Into House Probe Over Alleged COVID Vaccine Delay Through 2020 Election
June 30, 2025
Via Stocktwits
Topics Government Law Enforcement
Expert Outlook: BioNTech Through The Eyes Of 11 Analysts
June 25, 2025
Via Benzinga
5 Stocks To Ride The German Market Rally
June 16, 2025
Via Benzinga
Accenture To Rally More Than 13%? Here Are 10 Top Analyst Forecasts For Monday
June 16, 2025
Via Benzinga
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: CureVac N.V. (Nasdaq - CVAC), Know Labs, Inc. (NYSE American - KNW), Volato Group, Inc. (NYSE American - SOAR), Heliogen, Inc. (OTC - HLGN)
June 13, 2025
From Brodsky & Smith LLC
Via GlobeNewswire
Market Monitor News June 13 (Oracle UP - Gamestop DOWN)
June 13, 2025
Via Chartmill
Topics Artificial Intelligence Economy
BioNTech Expands mRNA Cancer Portfolio With CureVac $1.25 Billion All-Stock Deal
June 12, 2025
Via Benzinga
BioNTech To Acquire CureVac In All-Stock Deal Valued At $1.25B: Retail Sees Breakthrough In Cancer Treatment
June 12, 2025
Via Stocktwits
BioNTech Announces Strategic Transaction to Acquire CureVac in Public Exchange Offer
June 12, 2025
From BioNTech SE
Via GlobeNewswire
Global Billion Dollar Oncology Industry Experiencing Substantial Growth Driven by Increasing Cancer Incidences
June 11, 2025
Via FinancialNewsMedia
Topics Artificial Intelligence
Robert Kennedy Jr Axes Entire CDC Vaccine Panel To 'Restore Public Trust' — Pfizer, Moderna, Other Biotech Stocks Drop In After-Hours Trading
June 10, 2025
Via Benzinga
Global Billion Dollar Oncology Industry Experiencing Substantial Growth Driven by Increasing Cancer Incidences
June 11, 2025
From FN Media Group LLC
Via GlobeNewswire

Frequently Asked Questions

Is BioNTech SE - American Depositary Shares publicly traded?
Yes, BioNTech SE - American Depositary Shares is publicly traded.
What exchange does BioNTech SE - American Depositary Shares trade on?
BioNTech SE - American Depositary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for BioNTech SE - American Depositary Shares?
The ticker symbol for BioNTech SE - American Depositary Shares is BNTX on the Nasdaq Stock Market
What is the current price of BioNTech SE - American Depositary Shares?
The current price of BioNTech SE - American Depositary Shares is 107.15
When was BioNTech SE - American Depositary Shares last traded?
The last trade of BioNTech SE - American Depositary Shares was at 08/01/25 03:56 PM ET
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap